Current Evidence on Tobacco Harm Reduction in Pneumology: Interviews with Two Key Opinion Leaders

Amanda Barrell
{"title":"Current Evidence on Tobacco Harm Reduction in Pneumology: Interviews with Two Key Opinion Leaders","authors":"Amanda Barrell","doi":"10.33590/emj/10044289","DOIUrl":null,"url":null,"abstract":"The negative impact of smoking on the lung is well documented. Cigarette smoke is the cause of 90% of cases of chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. COPD is a progressive and debilitating condition with morbidity and mortality rates similar to myocardial infarction (MI) and stroke. Despite the widely recognised risks, millions of people continue to smoke, in some cases even after receiving a diagnosis of COPD and despite knowing that the habit will accelerate disease progression. While there is no doubt that smoking cessation is the most important health intervention for all cigarette smokers, it can be challenging. Nicotine addiction, social norms and culture, and the length of time it can take smokers to feel the adverse consequences of the habit all contribute to the high cessation failure rate. However, increasing clinical and epidemiological evidence indicates that for those who are unwilling or cannot stop smoking, harm reduction strategies can help reduce exposure to the harmful chemicals and carcinogens released during tobacco combustion. Electronic devices heat processed tobacco without combusting it to deliver an aerosol containing fewer toxic products or harmful and potentially harmful constituents (HPHC) than cigarette smoke. Clinical evidence to support their use is growing. In Japan, for example, a decrease in hospitalisations due to COPD exacerbation after the introduction of such heat-not-burn (HNB), or tobacco heating systems (THS), has been reported.\n\nIn this article, Wolfgang Popp, Döbling Doctor’s Center, Privatklinik Döbling, Vienna, Austria, and Klara Szondy, Semmelweis University, Budapest, Hungary, discuss the impact of cigarette smoke on the lung, and how to support smoking cessation in those willing and able to quit smoking. They also explain when strategies that reduce the harmful effects of smoking may be useful, and outline the latest evidence supporting the use of HNB systems.","PeriodicalId":90162,"journal":{"name":"European medical Journal. Urology","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European medical Journal. Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33590/emj/10044289","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The negative impact of smoking on the lung is well documented. Cigarette smoke is the cause of 90% of cases of chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. COPD is a progressive and debilitating condition with morbidity and mortality rates similar to myocardial infarction (MI) and stroke. Despite the widely recognised risks, millions of people continue to smoke, in some cases even after receiving a diagnosis of COPD and despite knowing that the habit will accelerate disease progression. While there is no doubt that smoking cessation is the most important health intervention for all cigarette smokers, it can be challenging. Nicotine addiction, social norms and culture, and the length of time it can take smokers to feel the adverse consequences of the habit all contribute to the high cessation failure rate. However, increasing clinical and epidemiological evidence indicates that for those who are unwilling or cannot stop smoking, harm reduction strategies can help reduce exposure to the harmful chemicals and carcinogens released during tobacco combustion. Electronic devices heat processed tobacco without combusting it to deliver an aerosol containing fewer toxic products or harmful and potentially harmful constituents (HPHC) than cigarette smoke. Clinical evidence to support their use is growing. In Japan, for example, a decrease in hospitalisations due to COPD exacerbation after the introduction of such heat-not-burn (HNB), or tobacco heating systems (THS), has been reported. In this article, Wolfgang Popp, Döbling Doctor’s Center, Privatklinik Döbling, Vienna, Austria, and Klara Szondy, Semmelweis University, Budapest, Hungary, discuss the impact of cigarette smoke on the lung, and how to support smoking cessation in those willing and able to quit smoking. They also explain when strategies that reduce the harmful effects of smoking may be useful, and outline the latest evidence supporting the use of HNB systems.
在肺炎方面减少烟草危害的现有证据:采访两位主要意见领袖
吸烟对肺部的负面影响有据可查。吸烟是90%的慢性阻塞性肺疾病(COPD)的病因,其中包括慢性支气管炎和肺气肿。慢性阻塞性肺病是一种进行性和衰弱性疾病,发病率和死亡率与心肌梗死(MI)和中风相似。尽管存在广泛认识到的风险,但仍有数百万人继续吸烟,在某些情况下,甚至在被诊断为慢性阻塞性肺病之后,尽管知道吸烟习惯会加速疾病进展。毫无疑问,戒烟是所有吸烟者最重要的健康干预措施,但它可能具有挑战性。尼古丁成瘾、社会规范和文化,以及吸烟者感受到这种习惯的不良后果所需的时间长度,都是导致戒烟失败率高的原因。然而,越来越多的临床和流行病学证据表明,对于那些不愿或不能戒烟的人,减少危害战略可以帮助减少接触烟草燃烧过程中释放的有害化学物质和致癌物。电子设备在不燃烧的情况下加热加工过的烟草,从而产生比香烟烟雾含有更少有毒产品或有害和潜在有害成分(HPHC)的气溶胶。支持其使用的临床证据越来越多。例如,在日本,有报道称,在采用这种加热不燃烧(HNB)或烟草加热系统(THS)后,因慢性阻塞性肺病加重而住院的人数有所减少。在这篇文章中,Wolfgang Popp (Döbling奥地利维也纳Privatklinik博士中心Döbling)和Klara Szondy(匈牙利布达佩斯Semmelweis大学)讨论了吸烟对肺部的影响,以及如何支持那些愿意并且能够戒烟的人戒烟。他们还解释了减少吸烟有害影响的策略何时可能有用,并概述了支持使用HNB系统的最新证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书